All In Biotech

Free tool

FAERS Monitor: Tobramycin Sulfate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050789 or its brand name (Tobramycin Sulfate, Tobramycin Sulfate). Reports on generic versions are filed under their own applications.

Reports

12,545

Serious

10,114

81% of reports

Hospitalization

6,073

Death reported

1,303

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pneumonia782
  • off label use778
  • drug ineffective710
  • acute kidney injury690
  • dyspnoea688
  • infective pulmonary exacerbation of cystic fibrosis624
  • death482
  • infection465
  • hospitalisation462
  • cough458
  • condition aggravated451
  • cystic fibrosis430
  • pyrexia428
  • fatigue403
  • nausea370

Reports by year received

View as table
YearReports
200486
2005104
200683
2007133
200898
2009104
2010114
2011213
2012207
2013171
2014283
2015449
2016506
2017561
20181,032
20191,557
20201,399
20211,030
2022981
2023832
20241,035
2025894
2026673

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,041,614 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infective pulmonary exacerbation of cystic fibrosisSignal624217.0200.0118,615
cystic fibrosisSignal430141.1128.155,055
acute kidney injurySignal6907.67.13,952
infectionSignal4655.44.91,669
hospitalisationSignal4625.14.61,505
pneumoniaSignal7824.13.81,822
coughSignal4582.72.5511
condition aggravatedSignal4512.52.3406
pyrexiaSignal4282.11.9241
dyspnoeaSignal6882.01.9373
off label use7781.51.4130
death4820.90.92
drug ineffective7100.90.88
fatigue4030.90.88
nausea3700.80.723

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.